Linked Data API

Show Search Form

Search Results

1141940
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Gambling: Rehabilitation more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 17 July (HL16963 and HL16964), what was the budget of Leeds and York Partnership NHS Trust for funding the NHS Northern Gambling Clinic; and what is the projected cost of that clinic in (1) 2020, (2) 2021, and (3) 2022. more like this
star this property tabling member printed
The Lord Bishop of St Albans more like this
star this property uin HL17484 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-06more like thismore than 2019-08-06
star this property answer text <p>NHS England and NHS Improvement have allocated £600,000 to Central and North West London NHS Foundation Trust and £370,000 to Leeds and York Partnership NHS Foundation Trust for gambling harm services provision in 2019/20, which includes funding for these clinics.</p><p> </p><p>GambleAware, an independent charity, is providing additional funding for these clinics. Information on this funding is not held centrally.</p><p> </p><p>Future years’ funding is not yet available.</p><p> </p><p> </p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17485 more like this
star this property question first answered
remove maximum value filtermore like thismore than 2019-08-06T14:58:10.86Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4308
unstar this property label Biography information for The Lord Bishop of St Albans more like this
1141957
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Breast Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what are the drugs approved by NICE to treat HER2+ breast cancer; and what assessment they have made of the efficacy of such drugs. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL17501 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for making recommendations for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources.</p><p>NICE has recommended the following drugs for the treatment of HER2-positive breast cancer: trastuzumab emtansine (Kadcyla) for treating HER2-positive advanced breast cancer after trastuzumab (Herceptin) and a taxane; pertuzumab (Perjeta) with trastuzumab (Herceptin) and docetaxel for treating HER2-positive breast cancer; pertuzumab (Perjeta) for the neoadjuvant treatment of HER2-positive breast cancer; and pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer.</p><p>NHS commissioners are legally required to fund drugs recommended in NICE technology appraisal guidance. It is for clinicians to decide on the most appropriate treatment for an individual patient based on their clinical judgement and in discussion with the patient.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17502 more like this
star this property question first answered
less than 2019-07-25T16:45:03.16Zmore like thismore than 2019-07-25T16:45:03.16Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1141958
star this property registered interest false more like this
star this property date less than 2019-07-24more like thismore than 2019-07-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pertuzumab more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what advice they provide to clinicians for the use of Pertuzumab rather than Herceptin for the treatment of HER2+ breast cancer. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL17502 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for making recommendations for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources.</p><p>NICE has recommended the following drugs for the treatment of HER2-positive breast cancer: trastuzumab emtansine (Kadcyla) for treating HER2-positive advanced breast cancer after trastuzumab (Herceptin) and a taxane; pertuzumab (Perjeta) with trastuzumab (Herceptin) and docetaxel for treating HER2-positive breast cancer; pertuzumab (Perjeta) for the neoadjuvant treatment of HER2-positive breast cancer; and pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer.</p><p>NHS commissioners are legally required to fund drugs recommended in NICE technology appraisal guidance. It is for clinicians to decide on the most appropriate treatment for an individual patient based on their clinical judgement and in discussion with the patient.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL17501 more like this
star this property question first answered
less than 2019-07-25T16:45:03.207Zmore like thismore than 2019-07-25T16:45:03.207Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
1141251
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when a long-term workforce plan which sets out the number of staff required to meet the current and future needs of cancer patients will be published. more like this
unstar this property tabling member constituency Denton and Reddish more like this
star this property tabling member printed
Andrew Gwynne more like this
star this property uin 280964 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The interim NHS People Plan, published on 3 June 2019, puts the workforce at the heart of the National Health Service and will ensure we have the staff needed to deliver high quality care. A final People Plan will be published soon after the conclusion of the 2019 Spending Review.</p><p>Phase 1 of the Cancer Workforce Plan for England, published in December 2017 by Health Education England (HEE), set out plans to expand capacity and skills in the cancer workforce, including targeting additional training support for seven priority professions which are key to cancer prevention, diagnosis and treatment, such as clinical radiology, histopathology, oncology and diagnostic and therapeutic radiography.</p><p>HEE will now work with NHS England and NHS Improvement to understand the longer-term workforce implications of further development of cancer services. This work will inform the final People Plan.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:30:43.603Zmore like thismore than 2019-08-05T11:30:43.603Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
1506
unstar this property label Biography information for Andrew Gwynne more like this
1141253
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential effect of the UK leaving the EU on the supply of drugs to the NHS. more like this
unstar this property tabling member constituency Tooting more like this
star this property tabling member printed
Dr Rosena Allin-Khan more like this
star this property uin 281022 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-02more like thismore than 2019-08-02
star this property answer text <p>The United Kingdom will leave the European Union on 31 October, with or without a deal. The Government would prefer the UK to leave the EU with a deal and, in the event that the UK leaves the EU with a new deal, the Department’s assessment is that access to medicines and medical devices will not change for industry or the National Health Service.</p><p>While the Prime Minister is confident that he can strike a new arrangement with the EU, it is vital that we prepare for a ‘no deal’ outcome. Therefore, as a responsible Government, we continue to take steps to ensure the supply of medicines and medical products is uninterrupted in a ‘no deal’ scenario.</p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>Ahead of 31 October, all necessary funding will be made available to support our ‘no deal’ preparations. On 1 August, Her Majesty’s Treasury announced an additional £434 million made available to help ensure continuity of supply of vital medicines and medical products, including through freight capacity, warehousing and stockpiling.</p><p>We are confident that the Department is doing everything appropriate to prepare for a possible ‘no deal’ EU exit on 31 October. We are working with our partners, including suppliers, freight companies and the health and social care system and our plans should ensure the supply of medicines and medical products remains uninterrupted.</p>
star this property answering member constituency Kingswood more like this
star this property answering member printed Chris Skidmore more like this
star this property question first answered
less than 2019-08-02T09:59:35.05Zmore like thismore than 2019-08-02T09:59:35.05Z
star this property answering member
4021
star this property label Biography information for Chris Skidmore more like this
star this property tabling member
4573
unstar this property label Biography information for Dr Rosena Allin-Khan more like this
1141255
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Non-surgical Cosmetic Procedures: Children more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what legal duties govern the administering of dermal fillers to people under the age of 18 by non-regulated practitioners. more like this
unstar this property tabling member constituency North Durham more like this
star this property tabling member printed
Mr Kevan Jones more like this
star this property uin 280927 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-25more like thismore than 2019-07-25
star this property answer text <p>Currently there are no restrictions that limit the administration of dermal fillers on young people under the age of 18 years old.</p><p>The Department is exploring options to introduce age restrictions on access to cosmetic procedures, bringing them in line with legislation on tattoos, teeth whitening and the use of sunbeds. From May 2020 all dermal fillers, irrespective of their composition and intended use, will be regulated as medical devices under Annex XVI of the Medical Device Regulations (EU 2017/745). The new Regulations will significantly improve the quality and safety of dermal fillers.</p><p>The Government is committed to improving the safety of cosmetic procedures through better training for practitioners, and clear information so that people can make informed decisions about their care. The growth in non-surgical treatments increases the need for consumer protection and we are currently working with stakeholders to strengthen the regulation of cosmetic procedures.</p><p>We urge anyone seeking a cosmetic procedure to take the time to find a reputable, insured and appropriately qualified practitioner who is either subject to statutory regulation or on a voluntary register accredited by the Professional Standards Authority.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2019-07-25T16:32:36.833Zmore like thismore than 2019-07-25T16:32:36.833Z
star this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price more like this
star this property tabling member
1438
unstar this property label Biography information for Mr Kevan Jones more like this
1141282
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Electronic Cigarettes: Health Hazards more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the increased numbers of people vaping on (a) nicotine addiction, (b) incidences of increased blood pressure and (c) heart attack rates. more like this
unstar this property tabling member constituency North East Hampshire more like this
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 281030 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>Public Health England (PHE) has published a series of reports on electronic cigarettes including the effects of vaping on health. The reports are available to view at the following link:</p><p><a href="https://www.gov.uk/government/collections/e-cigarettes-and-vaping-policy-regulation-and-guidance" target="_blank">https://www.gov.uk/government/collections/e-cigarettes-and-vaping-policy-regulation-and-guidance</a></p><p>While nicotine can contribute to raised blood pressure and cardiovascular risk, it is tar and carbon monoxide, which are the major sources of cardiovascular risk in cigarette smoke, producing nicotine vapour from a solution rather than by burning tobacco means that electronic cigarette vapour is free from almost all the toxic chemicals that accompany nicotine in cigarette smoke.</p><p>The Office for National Statistics has recorded the numbers of people using e-cigarettes since 2014 and the combined number of people using e-cigarettes and smoking has not increased since then. The proportion of people who smoke has decreased substantially in the same period.</p><p>PHE encourages people who both vape and smoke to stop smoking completely, because this greatly reduces health risks.</p><p><strong> </strong></p><p><strong> </strong></p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:25:52.907Zmore like thismore than 2019-08-05T11:25:52.907Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4498
unstar this property label Biography information for Mr Ranil Jayawardena more like this
1141283
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Electronic Cigarettes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban e-cigarettes wherever the smoking ban is in place. . more like this
unstar this property tabling member constituency North East Hampshire more like this
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 281031 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 281032 more like this
star this property question first answered
less than 2019-08-05T11:29:19.74Zmore like thismore than 2019-08-05T11:29:19.74Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4498
unstar this property label Biography information for Mr Ranil Jayawardena more like this
1141284
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Hospitals: Electronic Cigarettes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban (a) e-cigarette shops and (b) smoking on NHS hospital property. more like this
unstar this property tabling member constituency North East Hampshire more like this
star this property tabling member printed
Mr Ranil Jayawardena more like this
star this property uin 281032 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 281031 more like this
star this property question first answered
less than 2019-08-05T11:29:19.787Zmore like thismore than 2019-08-05T11:29:19.787Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4498
unstar this property label Biography information for Mr Ranil Jayawardena more like this
1141336
star this property registered interest false more like this
star this property date less than 2019-07-23more like thismore than 2019-07-23
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pharmacy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of community pharmacies. more like this
unstar this property tabling member constituency Harborough more like this
star this property tabling member printed
Neil O'Brien more like this
star this property uin 281058 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-08-05more like thismore than 2019-08-05
star this property answer text <p>The Government is not actively looking to increase the number of community pharmacies in England.</p><p>Applications to provide National Health Service pharmaceutical services continue to be determined by NHS England and NHS Improvement, informed by the local pharmaceutical needs assessment, which outlines the level of NHS pharmaceutical services provision in a given area, including if there are any gaps or unmet needs.</p><p>In England, access to NHS pharmaceutical services is good. There are over 11,500 community pharmacies, which is 12% more than a decade ago. This coverage means that 80% of the population live within 20 minutes walking distance of a community pharmacy, with more pharmacies in the most deprived areas.</p><p>Maintaining access to NHS pharmaceutical services remains an important priority for the Government. We will continue to maintain the good level of access we have in England through the Pharmacy Access Scheme, which provides additional financial support to pharmacies in areas where there are fewer pharmacies.</p>
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-08-05T11:27:19.42Zmore like thismore than 2019-08-05T11:27:19.42Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4679
unstar this property label Biography information for Neil O'Brien more like this